|
Sign In to gain access to subscriptions and/or personal tools.
|
Epididymal and Systemic Phospholipidosis in Rats and Dogs Treated with the Dopamine D3 Selective Antagonist PNU-177864
Daniel G. Rudmann
Pathology Sciences/Services Global Drug Safety Evaluation, Pfizer Inc., 7000 Portage Road, Kalamazoo, Michigan 49009, USA, rudmanndg{at}lilly.com
Mary E. Mcnerney
Reproductive Toxicology, Global Drug Safety Evaluation, Pfizer Inc., 7000 Portage Road, Kalamazoo, Michigan 49009, USA
Stacey L. Vandereide
Pathology Sciences/Services Global Drug Safety Evaluation, Pfizer Inc., 7000 Portage Road, Kalamazoo, Michigan 49009, USA
Joyce K. Schemmer
Pathology Sciences/Services Global Drug Safety Evaluation, Pfizer Inc., 7000 Portage Road, Kalamazoo, Michigan 49009, USA
Robert R. Eversole
Biological Imaging Center, Department of Biological Sciences, Western Michigan University, Kalamazoo, Michigan 49008, USA
Steven L. Vonderfecht
Pathology Sciences/Services Global Drug Safety Evaluation, Pfizer Inc., 7000 Portage Road, Kalamazoo, Michigan 49009, USA
Repeat dose oral toxicity studies were conducted in rat and dog to assess the safety for human clinical testing of the potent dopamine D3 receptor antagonist, PNU-177864. Systemic phospholipidosis was the principal treatment-related change with epididymal epithelial cell phospholipidosis being the most prominent finding in rats and dogs. Epididymal epithelial cells had no histologic evidence of degeneration; sperm density and morphology were normal histologically in both species; and sperm concentration, morphology, and motility in the dog were comparable to dogs given vehicle. Other sites with phospholipidosis included lymphoid tissues (lymph nodes, Peyer's patches, and/or spleen), pulmonary alveolar macrophages, and peripheral blood lymphocytes in rats and dogs and adrenal cortex, liver, pituitary, hair follicles, bone marrow lymphocytes and plasma cells, and skeletal muscle in rats only. The phospholipidosis was resolved after a 6-week recovery period in all tissues but epididymis. There was no evidence of cell injury in tissues that had phospholipid accumulations except in rat skeletal muscle that had multifocal myofiber degeneration and necrosis. For clinical trials, serum AST and CK and peripheral blood lymphocyte vacuolation were considered potential safety biomarkers for skeletal muscle degeneration and phospholipidosis, respectively.
Key Words: Dopamine • D3 receptors • phospholipidosis • dog • rat • biomarker • toxicity.
References
- Dake, M.D., Madison, J.M., Montgomery, C.K., Sheelito, J.E., Hinchcliffe, W.A., Winkles, M.L., and Bainton, D.F. (1985). Electron microscopic demonstration of lysosomal inclusion bodies in lung, liver, lymph nodes, and blood leukocytes of patients with amiodarone pulmonary toxicity. Amer J Med 78, 506—12.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Fardeau, M., Tome, F.M.S., and Simon, P. (1979). Muscle and nerve changes induced by perhexilin maleate in man and mice. Muscle Nerve 2, 24—36.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Feldman, S., Wang, M.-Y., and Kaloyanides, G.J. (1982). Aminoglycosides induce a phospholipidosis in renal cortex of the rat: An early manifestation of nephrotoxicity. J Pharmacol Exp Ther 220, 514—20.[Free Full Text]
- Guyton, A.C., and Hall, J.E. (1996). Endocrinology and Reproduction. In Textbook of Medical Physiology, 9th ed., P. 1006, W. B. Saunders Co. Philadelphia.
- Halliwell, W.H. (1997). Cationic amphiphilic drug-induced phospholipidosis. Toxicol Pathol 25, 53—60.[Abstract/Free Full Text]
- Hostetler, K.Y. (1984). Molecular studies of the induction of cellular phospholipidosis by cationic amphiphilic drugs. Federation Proc 43, 2582—5.[Web of Science][Medline]
[Order article via Infotrieve]
- Kumamato, T., Araki, S., Watanabe, S., Ikebe, N., and Fukuhara, N. (1989). Experimental chloroquine myopathy: Morphological and biochemical studies. Eur Neurol 29, 202—7.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Linder, R.E., Strader, L.F., Slott, V.L., and Suarez, J.D. (1992). Endpoints of spermatoxicity in the rat after short duration exposures to fourteen reproductive toxicants. Reprod Toxicol 6, 491—505.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Lullmann-Rauch, R. (1975). Chlorphentermine-induced abnormal cytoplasmic inclusions in peripheral blood cells of rats and guinea pigs. Toxicol Appl Pharmacol 32, 32—9.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Reasor, M.J. (1989). A review of the biology and toxicologic implication of the induction of lysosomal lamellar bodies by drugs. Toxicol Appl Pharmacol 97, 47—56.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Reasor, M.J., and Keyneman, C.A. (1983). Disaturated phosphatidylcholine in the pulmonary air spaces of rats treated with chlorphentermine. Biochem Pharmacol 32, 939—41.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Riva, E., Marchi, S., Pesenti, A., Bizzi, A., Cini, M., Veneroni, E., Tavbani, E., Boeri, R., Bertani, T., and Latini, R. (1987). Amiodarone induced phospholipidosis: Biochemical, morphological and functional changes in the lungs of rats chronically treated with amiodarone. Biochem Pharmacol 36, 3209—14.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Schmalbruch, H. (1980). The early changes in experimental myopathy induced by chloroquine and chlorphentermine. J Neuropath Exp Neurol 39, 65—81.[Web of Science][Medline]
[Order article via Infotrieve]
- Seed, J., Chapin, R.E., Clegg, E.D., Dostal, L.A., Foote, R.H., Hurtt, M.E., Klinefelter, G.R., Makris, S.L., Perreault, S.D., Schrader, S., Seyler, D., Sprando, R., Treinen, K.A., Veeramachaneni, D.N., and Wise, L.D. (1996). Methods for assessing sperm motility, morphology and counts in the rat, rabbit and dog: A consensus report. Reprod Toxicol 10, 237—45.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Vonderfecht, S.L., Stone, M.L., Eversole, R.R., Yancey, M.F., Schuette, M.R., Duncan, B.A., and Ware, J.A. (2004). Myopathy related to administration of a cationic amphiphilic drug and the use of multidose drug distribution analysis to predict its occurrence. Toxicol Pathol 32(3), 318—325.[Abstract/Free Full Text]
- Yano, B.L., Bond, D.M., Novilla, M.N., McFadden, L.G., and Reasor, M.J. (2002). Spinosad insecticide: Subchronic and chronic toxicity and lack of carcinogenicity in Fischer 344 rats. Toxicol Sci 65, 288—98.[Abstract/Free Full Text]
Toxicologic Pathology, Vol. 32, No. 3,
326-332 (2004)
DOI: 10.1080/01926230490431754
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
S. L. Vonderfecht, M. L. Stone, R. R. Eversole, M. F. Yancey, M. R. Schuette, B. A. Duncan, and J. A. Ware
Myopathy Related to Administration of a Cationic Amphiphilic Drug and the Use of Multidose Drug Distribution Analysis to Predict its Occurrence
Toxicol Pathol,
April 1, 2004;
32(3):
318 - 325.
[Abstract]
[PDF]
|
|
|
|
|
